Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 158 clinical trials
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

with acute myeloid leukemia. This study involves the following: Venetoclax and azacitidine (investigational combination) Cytarabine and idarubicin or daunorubicin (per

gilbert's syndrome
daunorubicin
ejection fraction
myelodysplasia
cytarabine/daunorubicin
  • 0 views
  • 26 Mar, 2022
  • 2 locations
Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage

The purpose of this study is to test the safety and determine the best dose of venetoclax and cytarabine when given with or without idarubicin in treating pediatric patients with acute myeloid

refractory acute myeloid leukemia (aml)
ejection fraction
acute leukemia
graft versus host disease
direct bilirubin
  • 107 views
  • 20 Apr, 2022
  • 2 locations
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

This phase II trial compares three chemotherapy regimens consisting of bendamustine, rituximab, high dose cytarabine, and acalabrutinib and studies how well they work in treating patients with

gilbert's syndrome
rituximab
monoclonal antibodies
acalabrutinib
mantle cell lymphoma
  • 67 views
  • 17 Feb, 2022
  • 303 locations
The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS

This clinical trial is to test if a 28-channel ECG (MECG) system would efficiently differentiate the patients suspected to have CAD or ACS with acceptable sensitivity and specificity, and optimize this portable self-built-in multichannel ECG recorder system with various algorithms. The 28-channel ECG (MECG) system is a multi-channel real-time cardiovascular …

  • 0 views
  • 18 Mar, 2021
  • 1 location
Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia

This will be an open-label, Phase 1B/2A, study to characterize the efficacy, safety, pharmacokinetics, and pharmacodynamics of fosciclopirox administered alone and in combination with cytarabine

  • 0 views
  • 20 Oct, 2021
  • 1 location
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

This phase II trial studies how well cytarabine and idarubicin or daunorubicin with or without pembrolizumab work in treating patients with newly-diagnosed acute myeloid leukemia. Chemotherapy

cell transplantation
daunorubicin
chronic myelomonocytic leukemia
direct bilirubin
cancer
  • 0 views
  • 02 Jan, 2022
  • 9 locations
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

This phase I trial finds the best dose and side effects of venetoclax in combination with cladribine, cytarabine, granulocyte colony-stimulating factor, and mitoxantrone (CLAG-M) in treating

gilbert's syndrome
ejection fraction
granulocyte colony stimulating factor
acute leukemia
cancer
  • 0 views
  • 13 May, 2022
  • 1 location
MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

cytarabine as a possible treatment for the patient AML.

cytarabine/daunorubicin
gilbert's syndrome
cytarabine
secondary acute myeloid leukemia
daunorubicin
  • 1 views
  • 23 Feb, 2022
  • 1 location
[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

rituximab and cytarabine.

rituximab
b-cell lymphoma
neutrophil count
hodgkin's lymphoma
cytarabine
  • 1 views
  • 13 Feb, 2022
  • 1 location
Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Comparison of the efficacy and safety of rituximab combined with fotemustine, pemetrexed, dexamethasone and rituximab in combination with methotrexate, cytarabine and dexamethasone as first-line

  • 0 views
  • 23 Jan, 2021
  • 1 location